FOLFOX Plus Regorafenib in Patients With Unresectable or Metastatic Esophagogastric Cancer
Clinical trial NCT01913639 · COMPLETED
Trial details
- NCT number
- NCT01913639
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2019-06-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.